N. Fichter

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Luigi Bartalena, George J. Kahaly, L. Baldeschi et al. · European Journal of Endocrinology · 2021 · 977 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

George J. Kahaly, Michaela Riedl, J. König et al. · The Lancet Diabetes & Endocrinology · 2018 · 216 citations

Pharmacy, Endocrinology, Pharmacotherapy +9

PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012

Petros Perros, Miloš Žarković, Claudio Azzolini et al. · British Journal of Ophthalmology · 2015 · 119 citations · Full text

Medicine, Endocrinology, Internal Medicine +13

Predictive score for the development or progression of Graves’ orbitopathy in patients with newly diagnosed Graves’ hyperthyroidism

Wilmar M. Wiersinga, Miloš Žarković, Luigi Bartalena et al. · European Journal of Endocrinology · 2018 · 93 citations · Full text

Medicine, Endocrinology, Clinical Epidemiology +13

Functional and Esthetic Outcome after Bony Lateral Wall Decompression with Orbital Rim Removal and Additional Fat Resection in Graves’ Orbitopathy with Regard to the Configuration of the Lateral Canthal Region

N. Fichter, Helga Krentz, Rudolf Guthoff · Orbit · 2013 · 49 citations

Medicine, Ophthalmology, Surgery +14